11/13
12:53 pm
nmra
Neumora Therapeutics, Inc. (NASDAQ: NMRA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Low
Report
Neumora Therapeutics, Inc. (NASDAQ: NMRA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
11/13
08:06 am
nmra
Neumora Therapeutics, Inc. (NASDAQ: NMRA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
Medium
Report
Neumora Therapeutics, Inc. (NASDAQ: NMRA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
11/13
05:08 am
nmra
Rating for NMRA
Medium
Report
Rating for NMRA
11/13
05:08 am
nmra
Rating for NMRA
Medium
Report
Rating for NMRA
11/5
07:14 am
nmra
Rating for NMRA
Medium
Report
Rating for NMRA
11/5
07:00 am
nmra
Neumora Therapeutics, Inc. (NASDAQ: NMRA) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $15.00 price target on the stock, down previously from $18.00.
Medium
Report
Neumora Therapeutics, Inc. (NASDAQ: NMRA) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $15.00 price target on the stock, down previously from $18.00.
10/18
08:33 am
nmra
Neumora Therapeutics, Inc. (NASDAQ: NMRA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
Low
Report
Neumora Therapeutics, Inc. (NASDAQ: NMRA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
10/18
06:04 am
nmra
Rating for NMRA
Low
Report
Rating for NMRA
10/18
06:04 am
nmra
Rating for NMRA
Low
Report
Rating for NMRA
10/1
07:57 am
nmra
Neumora Therapeutics, Inc. (NASDAQ: NMRA) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $30.00 price target on the stock.
Low
Report
Neumora Therapeutics, Inc. (NASDAQ: NMRA) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $30.00 price target on the stock.
9/12
02:15 pm
nmra
Neumora Therapeutics, Inc. (NASDAQ: NMRA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
Low
Report
Neumora Therapeutics, Inc. (NASDAQ: NMRA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
9/12
01:29 pm
nmra
Rating for NMRA
Low
Report
Rating for NMRA
9/12
01:29 pm
nmra
Rating for NMRA
Low
Report
Rating for NMRA
9/4
10:05 am
nmra
Neumora Therapeutics, Inc. (NASDAQ: NMRA) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $29.00 price target on the stock.
Medium
Report
Neumora Therapeutics, Inc. (NASDAQ: NMRA) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $29.00 price target on the stock.
9/4
10:05 am
nmra
Neumora Therapeutics, Inc. (NASDAQ: NMRA) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $29.00 price target on the stock.
Medium
Report
Neumora Therapeutics, Inc. (NASDAQ: NMRA) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $29.00 price target on the stock.
9/4
09:55 am
nmra
Rating for NMRA
Low
Report
Rating for NMRA
9/4
09:55 am
nmra
Rating for NMRA
Low
Report
Rating for NMRA